Westkaemper RB - Search Results

1

Potential modes of interaction of 9-aminomethyl-9,10-dihydroanthracene (AMDA) derivatives with the 5-HT2A receptor: a ligand structure-affinity relationship, receptor mutagenesis and receptor modeling investigation.

Runyon SP, Mosier PD, Roth BL, Glennon RA, Westkaemper RB. Runyon SP, et al. Among authors: westkaemper rb. J Med Chem. 2008 Nov 13;51(21):6808-28. doi: 10.1021/jm800771x. Epub 2008 Oct 11. J Med Chem. 2008. PMID: 18847250 Free PMC article.

2

Geometry-affinity relationships of the selective serotonin receptor ligand 9-(aminomethyl)-9,10-dihydroanthracene.

Runyon SP, Peddi S, Savage JE, Roth BL, Glennon RA, Westkaemper RB. Runyon SP, et al. Among authors: westkaemper rb. J Med Chem. 2002 Apr 11;45(8):1656-64. doi: 10.1021/jm010354g. J Med Chem. 2002. PMID: 11931619

3

Application of ligand SAR, receptor modeling and receptor mutagenesis to the discovery and development of a new class of 5-HT(2A) ligands.

Westkaemper RB, Glennon RA. Westkaemper RB, et al. Curr Top Med Chem. 2002 Jun;2(6):575-98. doi: 10.2174/1568026023393741. Curr Top Med Chem. 2002. PMID: 12052195 Review.

4

Ring substituted analogues of 5-aminomethyl-10,11-dihydro-dibenzo[a,d]cycloheptene (AMDH): potential modes of binding to the 5-HT(2A) receptor.

Peddi S, Roth BL, Glennon RA, Westkaemper RB. Peddi S, et al. Among authors: westkaemper rb. Bioorg Med Chem Lett. 2003 Aug 4;13(15):2565-8. doi: 10.1016/s0960-894x(03)00504-3. Bioorg Med Chem Lett. 2003. PMID: 12852967

5

Spiro[9,10-dihydroanthracene]-9,3'-pyrrolidine-a structurally unique tetracyclic 5-HT2A receptor antagonist.

Peddi S, Roth BL, Glennon RA, Westkaemper RB. Peddi S, et al. Among authors: westkaemper rb. Eur J Pharmacol. 2003 Dec 15;482(1-3):335-7. doi: 10.1016/j.ejphar.2003.09.059. Eur J Pharmacol. 2003. PMID: 14660041

6

Structural determinants for high 5-HT(2A) receptor affinity of spiro[9,10-dihydroanthracene]-9,3(')-pyrrolidine (SpAMDA).

Peddi S, Roth BL, Glennon RA, Westkaemper RB. Peddi S, et al. Among authors: westkaemper rb. Bioorg Med Chem Lett. 2004 May 3;14(9):2279-83. doi: 10.1016/j.bmcl.2004.02.014. Bioorg Med Chem Lett. 2004. PMID: 15081025

7

Possible differences in modes of agonist and antagonist binding at human 5-HT6 receptors.

Pullagurla MR, Westkaemper RB, Glennon RA. Pullagurla MR, et al. Among authors: westkaemper rb. Bioorg Med Chem Lett. 2004 Sep 6;14(17):4569-73. doi: 10.1016/j.bmcl.2004.05.076. Bioorg Med Chem Lett. 2004. PMID: 15357994

8

Methoxy-substituted 9-aminomethyl-9,10-dihydroanthracene (AMDA) derivatives exhibit differential binding affinities at the 5-HT(2A) receptor.

Dewkar GK, Peddi S, Mosier PD, Roth BL, Westkaemper RB. Dewkar GK, et al. Among authors: westkaemper rb. Bioorg Med Chem Lett. 2008 Oct 1;18(19):5268-71. doi: 10.1016/j.bmcl.2008.08.059. Epub 2008 Aug 22. Bioorg Med Chem Lett. 2008. PMID: 18774714 Free PMC article.

9

Synthesis, structure-affinity relationships, and modeling of AMDA analogs at 5-HT2A and H1 receptors: structural factors contributing to selectivity.

Shah JR, Mosier PD, Roth BL, Kellogg GE, Westkaemper RB. Shah JR, et al. Among authors: westkaemper rb. Bioorg Med Chem. 2009 Sep 15;17(18):6496-504. doi: 10.1016/j.bmc.2009.08.016. Epub 2009 Aug 13. Bioorg Med Chem. 2009. PMID: 19700330 Free PMC article.

10

9-Aminomethyl-9,10-dihydroanthracene (AMDA) analogs as structural probes for steric tolerance in 5-HT2A and H1 receptor binding sites.

Shah JR, Mosier PD, Peddi S, Roth BL, Westkaemper RB. Shah JR, et al. Among authors: westkaemper rb. Bioorg Med Chem Lett. 2010 Feb 1;20(3):935-8. doi: 10.1016/j.bmcl.2009.12.064. Epub 2009 Dec 23. Bioorg Med Chem Lett. 2010. PMID: 20045641 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Search Page

Filters